Latest DNA Chip Stories
LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery technologies, announced today the publication of over 250 peer-reviewed studies using the companyâ€™s microarray service for analyzing miRNA expression profiles.
SUNNYVALE, Calif., June 8, 2011 /PRNewswire/ -- Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced the launch of the GenePixÂ® SL50 Slide Loader and GenePixÂ® Pro 7.2 Software for an accelerated microarray workflow.
DALLAS, May 17, 2011 /PRNewswire/ -- The "Global DNA and Gene Chip (Microarrays) Market (2008 - 2015)" analyzes the DNA microarray market by types and applications and studies the major market drivers, restraints, opportunities, and market trends for the DNA microarray market in North America, Europe, Asia, and Rest of the World. Browse market data tables and in-depth TOC on Global DNA and Gene Chip (Microarrays) Market (2008 - 2015)....
WOBURN, Mass., March 22, 2011 /PRNewswire/ -- Avantra Biosciences has announced they are selling their new and improved proprietary PATHÂ® Protein Microarray Ultra-thin Nitrocellulose Slides.
BELMONT, Calif., March 16, 2011 /PRNewswire/ -- Phalanx Biotech Group, a global provider of genomic analysis services, announces its newest expression microarray - the Rat Whole Genome OneArrayÂ®.
Antibodies are watchdogs of human health, continuously prowling the body and registering minute changes associated with infection or disease with astonishing acuity.
Researchers at the Allen Institute for Brain Science and SRI International have published the most systematic study to date of the effects of sleep deprivation on gene expression in the brain.
Two women taking part in the world's first controlled study of a comprehensive genetic screening test before IVF have given birth to healthy babies.
CAMBRIDGE, Mass., Sept.
An international consortium of genetics experts has issued a consensus statement recommending chromosomal microarray (CMA) as the new standard practice for genetic evaluation of children with unexplained developmental delay, autism or birth defects.
- Growing in low tufty patches.